Insider Trading Activity Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) – CEO Bought 20,000 shares of Stock

ME Staff

7 years ago

Insider Trading Activity For Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

Seth Lederman , CEO of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) reportedly Bought 20,000 shares of the company’s stock at an average price of 3 for a total transaction amount of $60,000.00 SEC Form

Insider Trading History For Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

On 9/27/2013 Charles E Iv Mather, Director, bought 1,000 with an average share price of $3.65 per share and the total transaction amounting to $3,650.00.View SEC Filing

On 2/9/2015 Leland Gershell, CFO, bought 5,000 with an average share price of $5.85 per share and the total transaction amounting to $29,250.00.View SEC Filing

On 2/9/2015 Ernest Mario, Director, bought 30,000 with an average share price of $5.85 per share and the total transaction amounting to $175,500.00.View SEC Filing

On 3/5/2015 Seth Lederman, CEO, bought 2,000 with an average share price of $6.27 per share and the total transaction amounting to $12,540.00.View SEC Filing

On 3/6/2015 Ernest Mario, Director, bought 4,000 with an average share price of $6.57 per share and the total transaction amounting to $26,280.00.View SEC Filing

On 3/9/2015 Seth Lederman, CEO, bought 2,000 with an average share price of $6.48 per share and the total transaction amounting to $12,960.00.View SEC Filing

On 3/10/2015 Charles E Iv Mather, Director, bought 1,000 with an average share price of $6.80 per share and the total transaction amounting to $6,800.00.View SEC Filing

Analyst Ratings For Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
These are 2 Hold Ratings, 2 Buy Ratings .
The current consensus rating for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is Buy (Score: 2.50) with a consensus target price of $7.00 , a potential (137.29% upside)

Analyst Ratings History For Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

On 9/7/2016 Cantor Fitzgerald Downgraded rating Buy to Hold
On 12/20/2016 Oppenheimer Holdings, Inc. Reiterated Rating Hold
On 6/26/2017 Aegis Initiated Coverage of rating Buy with a price target of $10.00
On 8/18/2017 Roth Capital Upgraded rating Neutral to Buy with a price target of $6.00

Recent Trading Activity for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
Shares of Tonix Pharmaceuticals Holding Corp. closed the previous trading session at 2.95 down -0.02 -0.84% with 87,567 shares trading hands.